Cash flow Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange Other stock markets 03:58:53 2024-12-06 pm EST			5-day change	1st Jan Change
0.1750 ^CAD	+9.38%		+25.00%	+75.00%

Dec. 02	Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding	CI
Oct. 24	Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024	CI

9738e0d58b17de68d17f6959979.mqmQX83Q8l3U6Oa-lSsiHeATV05DruqhNMc-UelVq8M.o8PRFImdwTOApaf2xF9LUrllLgAy76TTfvVGGI4U8qXIzfgPppi0Apegqw

Published financial data: ENTHEON BIOMEDICAL CORP.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: November	2019	2020	2021	2022	2023
Revenues	-	-	21.67K	190K	250K
Total Revenues	-	-	21.67K	190K	250K
Cost of Goods Sold, Total	-	-	12.54K	-	-
Gross Profit	-	-	9.13K	190K	250K
Selling General & Admin Expenses, Total	657K	1.2M	4.58M	2.5M	563K
Stock-Based Compensation (IS)	-	-	2.55M	85.31K	1.18K
R&D Expenses	-	443K	1.49M	1.2M	-
Depreciation & Amortization - (IS)	-	2.72K	488K	2.1K	-
Other Operating Expenses, Total	657K	1.64M	9.12M	3.79M	564K
Operating Income	-657K	-1.64M	-9.11M	-3.6M	-314K
Interest And Investment Income	-	7.36K	10.41K	756	7.32K
Net Interest Expenses	-	7.36K	10.41K	756	7.32K
Currency Exchange Gains (Loss)	-	-	-	20.92K	-201
Other Non Operating Income (Expenses)	-10.37K	-8.37K	3.05K	250K	2.47K
EBT, Excl. Unusual Items	-667K	-1.64M	-9.09M	-3.33M	-304K
Gain (Loss) On Sale Of Investments	-	49.1K	206K	-69.33K	4.4K
Gain (Loss) On Sale Of Assets	-	-	-	1.34M	-
Other Unusual Items	-	-2.79M	-	-	-
EBT, Incl. Unusual Items	-667K	-4.38M	-8.89M	-2.06M	-300K
Earnings From Continuing Operations	-667K	-4.38M	-8.89M	-2.06M	-300K
Earnings Of Discontinued Operations	-	-	-	-6.46M	-
Net Income to Company	-667K	-4.38M	-8.89M	-8.52M	-300K
Net Income - (IS)	-667K	-4.38M	-8.89M	-8.52M	-300K
Net Income to Common Incl Extra Items	-667K	-4.38M	-8.89M	-8.52M	-300K
Net Income to Common Excl. Extra Items	-667K	-4.38M	-8.89M	-2.06M	-300K
Per Share Items
Net EPS - Basic	-4.7	-1.6	-1.64	-1.44	-0.05
Basic EPS - Continuing Operations	-4.7	-1.6	-1.64	-0.35	-0.05
Basic Weighted Average Shares Outstanding	142K	2.74M	5.43M	5.91M	5.91M
Net EPS - Diluted	-5.04	-1.6	-1.64	-1.44	-0.05
Diluted EPS - Continuing Operations	-5.04	-1.6	-1.64	-0.35	-0.05
Diluted Weighted Average Shares Outstanding	142K	2.74M	5.43M	5.91M	5.91M
Normalized Basic EPS	-2.94	-0.37	-1.05	-0.35	-0.03
Normalized Diluted EPS	-2.94	-0.37	-1.05	-0.35	-0.03
Supplemental Items
EBITDA	-	-1.64M	-9.07M	-3.54M	-
EBITA	-657K	-1.64M	-9.11M	-3.6M	-314K
EBIT	-657K	-1.64M	-9.11M	-3.6M	-314K
Total Revenues (As Reported)	-	-	-	190K	250K
Normalized Net Income	-417K	-1.03M	-5.68M	-2.08M	-190K
Supplemental Operating Expense Items
Marketing Expenses	32.17K	-	-	-	-
Selling and Marketing Expenses	77.2K	-	-	-	-
General and Administrative Expenses	490K	1.2M	4.58M	2.5M	563K
Research And Development Expense From Footnotes	-	443K	1.49M	1.2M	-
Net Rental Expense, Total	14.82K	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	2.55M	224K	1.18K
Total Stock-Based Compensation	-	-	2.55M	224K	1.18K

Fiscal Period: November	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	113K	2.79M	2.05M	680K	345K
Short Term Investments	-	50K	-	-	-
Total Cash And Short Term Investments	113K	2.84M	2.05M	680K	345K
Other Receivables	2.9K	76.43K	28.3K	42.19K	6.23K
Total Receivables	2.9K	76.43K	28.3K	42.19K	6.23K
Inventory	-	-	26.19K	-	-
Prepaid Expenses	21.31K	1.49M	1.1M	21.86K	45.21K
Total Current Assets	137K	4.4M	3.21M	744K	396K
Gross Property Plant And Equipment	-	-	202K	-	-
Accumulated Depreciation	-	-	-38.1K	-	-
Net Property Plant And Equipment	-	6.31K	164K	-	-
Long-term Investments	-	62.33K	703K	-	-
Other Intangibles, Total	-	-	5.9M	-	-
Other Long-Term Assets, Total	-	-	-	25K	5K
Total Assets	137K	4.47M	9.98M	769K	401K
Liabilities
Accounts Payable, Total	87.81K	724K	928K	140K	84.67K
Accrued Expenses, Total	3.85K	4.57K	-	15.15K	659
Short-term Borrowings	3.03K	-	-	-	-
Total Current Liabilities	94.69K	728K	928K	155K	85.33K
Total Liabilities	94.69K	728K	928K	155K	85.33K
Common Stock, Total	317K	7.15M	19.35M	19.35M	19.96M
Retained Earnings	-278K	-4.66M	-13.55M	-21.61M	-21.31M
Comprehensive Income and Other	3.63K	1.26M	3.24M	2.87M	1.66M
Total Common Equity	42.17K	3.74M	9.05M	615K	316K
Total Equity	42.17K	3.74M	9.05M	615K	316K
Total Liabilities And Equity	137K	4.47M	9.98M	769K	401K
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.98M	4.04M	5.91M	5.91M	5.91M
ECS Total Common Shares Outstanding	2.08M	4.04M	5.91M	5.91M	5.91M
Book Value / Share	0.02	0.93	1.53	0.1	0.05
Tangible Book Value	42.17K	3.74M	3.15M	615K	316K
Tangible Book Value Per Share	0.02	0.93	0.53	0.1	0.05
Total Debt	3.03K	0	0	0	0
Net Debt	-110K	-2.84M	-2.05M	-680K	-345K
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	-	-	163K	-	-
Full Time Employees	-	3	-	2	2

Fiscal Period: November	2019	2020	2021	2022	2023
Net Income	-667K	-4.38M	-8.89M	-8.52M	-300K
Depreciation & Amortization - CF	-	2.72K	35.7K	-648K	-
Depreciation & Amortization, Total	-	2.72K	35.7K	-648K	-
Amortization of Deferred Charges, Total - (CF)	-	-	452K	651K	-
(Gain) Loss From Sale Of Asset	-	-	-	1.71K	-
(Gain) Loss on Sale of Investments - (CF)	-	-49.1K	-206K	69.33K	-4.4K
Stock-Based Compensation (CF)	-	-	2.55M	85.31K	1.18K
Net Cash From Discontinued Operations	-	-	-	-512K	-
Other Operating Activities, Total	8.71K	2.79M	-	6.46M	-
Change In Accounts Receivable	-6.96K	-66.11K	77.81K	-7.22K	35.88K
Change In Inventories	-	-	881	-	-
Change In Accounts Payable	243K	-207K	-29.26K	-634K	-69.32K
Change in Other Net Operating Assets	-51.15K	-925K	388K	1.08M	-23.27K
Cash from Operations	-473K	-2.84M	-5.62M	-1.98M	-360K
Capital Expenditure	-	-9.03K	-97.97K	-	-
Cash Acquisitions	-	1.15M	441K	-	-
Investment in Marketable and Equity Securities, Total	-	-	-385K	634K	4.4K
Other Investing Activities, Total	-	-62.91K	-56.81K	-25K	20K
Cash from Investing	-	1.08M	-98.87K	609K	24.4K
Short Term Debt Issued, Total	60.55K	-	-	-	-
Total Debt Issued	145K	-	-	-	-
Short Term Debt Repaid, Total	-7.52K	-3.03K	-	-	-
Total Debt Repaid	-18.06K	-3.03K	-	-	-
Issuance of Common Stock	616K	4.38M	5.11M	-	-
Other Financing Activities, Total	-	47.88K	-131K	-	-
Cash from Financing	744K	4.43M	4.98M	-	-
Net Change in Cash	270K	2.67M	-738K	-1.37M	-336K
Supplemental Items
Levered Free Cash Flow	-	-1.94M	-2.14M	-1.7M	-252K
Unlevered Free Cash Flow	-	-1.94M	-2.14M	-1.7M	-252K
Change In Net Working Capital	-	907K	-608K	-322K	56.71K
Net Debt Issued / Repaid	127K	-3.03K	-	-	-

Fiscal Period: November	2019	2020	2021	2022	2023
Profitability
Return on Assets	-	-44.49	-78.77	-41.88	-33.54
Return on Total Capital	-	-54.11	-88.96	-46.57	-42.19
Return On Equity %	-	-231.39	-138.91	-42.66	-64.49
Return on Common Equity	-	-231.39	-138.91	-42.66	-64.49
Margin Analysis
Gross Profit Margin %	-	-	42.13	100	100
SG&A Margin	-	-	21.14K	1.32K	224.96
EBITDA Margin %	-	-	-41.86K	-1.87K	-
EBITA Margin %	-	-	-42.02K	-1.9K	-125.43
EBIT Margin %	-	-	-42.02K	-1.9K	-125.43
Income From Continuing Operations Margin %	-	-	-41.01K	-1.09K	-119.85
Net Income Margin %	-	-	-41.01K	-4.49K	-119.85
Net Avail. For Common Margin %	-	-	-41.01K	-1.09K	-119.85
Normalized Net Income Margin	-	-	-26.23K	-1.1K	-76
Levered Free Cash Flow Margin	-	-	-9.88K	-897.27	-100.58
Unlevered Free Cash Flow Margin	-	-	-9.88K	-897.27	-100.58
Asset Turnover
Asset Turnover	-	-	0	0.04	0.43
Fixed Assets Turnover	-	-	0.25	-	-
Short Term Liquidity
Current Ratio	1.45	6.05	3.46	4.81	4.64
Quick Ratio	1.22	4	2.24	4.67	4.11
Operating Cash Flow to Current Liabilities	-5	-3.9	-6.05	-12.79	-4.22
Long Term Solvency
Total Debt/Equity	7.18	-	-	-	-
Total Debt / Total Capital	6.7	-	-	-	-
Total Liabilities / Total Assets	69.19	16.28	9.3	20.1	21.27
Net Debt / EBITDA	-	1.73	0.23	0.19	-
Net Debt / (EBITDA - Capex)	-	1.72	0.22	0.19	-
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	31.97
Gross Profit, 1 Yr. Growth %	-	-	-	-	31.97
EBITDA, 1 Yr. Growth %	-	-	453.75	-56.68	-
EBITA, 1 Yr. Growth %	-	149.14	455	-56.17	-91.28
EBIT, 1 Yr. Growth %	-	149.14	455	-56.17	-91.28
Earnings From Cont. Operations, 1 Yr. Growth %	-	556.63	102.82	-74.23	-85.45
Net Income, 1 Yr. Growth %	-	556.63	102.82	-4.12	-96.48
Normalized Net Income, 1 Yr. Growth %	-	146.04	107.71	-59.43	-90.86
Diluted EPS Before Extra, 1 Yr. Growth %	-	2	2.52	-76.32	-85.45
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	2.5K	-	-
Total Assets, 1 Yr. Growth %	-	3.17K	123.06	-92.29	-47.86
Tangible Book Value, 1 Yr. Growth %	-	8.78K	-15.94	-80.48	-48.62
Common Equity, 1 Yr. Growth %	-	8.78K	141.66	-93.21	-48.62
Cash From Operations, 1 Yr. Growth %	-	499.55	97.89	-62.89	-81.59
Capital Expenditures, 1 Yr. Growth %	-	-	984.58	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-	-	10.48	-13.62	-85.21
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	10.48	-13.62	-85.21
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-	-	47.07	-
EBITA, 2 Yr. CAGR %	-	-	271.85	48.13	-80.45
EBIT, 2 Yr. CAGR %	-	-	271.85	48.13	-80.45
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	264.94	-31.41	-80.63
Net Income, 2 Yr. CAGR %	-	-	264.94	39.45	-81.63
Normalized Net Income, 2 Yr. CAGR %	-	-	269.15	-12.8	-80.74
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	2.26	-53.26	-81.44
Total Assets, 2 Yr. CAGR %	-	-	753.82	-58.53	-79.95
Tangible Book Value, 2 Yr. CAGR %	-	-	763.98	-59.49	-68.33
Common Equity, 2 Yr. CAGR %	-	-	1.36K	-59.49	-81.32
Cash From Operations, 2 Yr. CAGR %	-	-	244.45	-16.51	-74.01
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-6.3	-64.25
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-6.3	-64.25
Compound Annual Growth Rate Over Three Years
EBITA, 3 Yr. CAGR %	-	-	-	76.16	-42.37
EBIT, 3 Yr. CAGR %	-	-	-	76.16	-42.37
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	45.64	-59.09
Net Income, 3 Yr. CAGR %	-	-	-	133.74	-59.09
Normalized Net Income, 3 Yr. CAGR %	-	-	-	70.87	-58.88
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-39.37	-68.32
Total Assets, 3 Yr. CAGR %	-	-	-	77.79	-55.24
Tangible Book Value, 3 Yr. CAGR %	-	-	-	144.25	-56.15
Common Equity, 3 Yr. CAGR %	-	-	-	144.25	-56.15
Cash From Operations, 3 Yr. CAGR %	-	-	-	61.07	-49.76
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-49.36
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-49.36